12:00 AM
 | 
May 06, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Navidea, Cardinal Health sales and marketing update

Navidea and Cardinal Health launched Lymphoseek tilmanocept in the U.S. for use in intraoperative lymphatic imaging in breast cancer and melanoma patients. Navidea priced Lymphoseek at $300 per patient...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >